期刊文献+

安徽省滁州地区2013年细菌耐药性监测 被引量:5

Surveillance of bacterial resistance from hospitals in Anhui Chuzhou Area in 2013
在线阅读 下载PDF
导出
摘要 目的了解2013年安徽省滁州地区细菌耐药性监测结果。方法采用纸片扩散法(K-B)对滁州地区3所医院所分离菌株进行药敏试验,按CLSI 2012年版标准判断结果;采用WHONET5.6进行耐药性分析。结果共收集临床分离菌2 927株,其中革兰阳性菌763株,占26.1%;革兰阴性菌2 164株,占73.9%。葡萄球菌属中耐甲氧西林金黄色葡萄球菌(MRSA)和耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)分别占金黄色葡萄球菌和凝固酶阴性葡萄球菌的33.2%和85.9%。葡萄球菌属和肠球菌属中未见万古霉素和利奈唑胺耐药株。大肠埃希菌、克雷伯菌属(肺炎克雷伯菌和产酸克雷伯菌)和奇异变形杆菌产超广谱β内酰胺酶的检出率分别为56.9%、31.3%和22.8%。肠杆菌科细菌对美罗培南和亚胺培南较敏感。铜绿假单胞菌对美罗培南、亚胺培南、阿米卡星、哌拉西林-他唑巴坦和头孢他啶的耐药率均低于30%。不动杆菌属对美罗培南和亚胺培南的耐药率分别为58.1%和50.2%。结论细菌的耐药性日趋严重,对多重耐药和泛耐药菌株应引起高度重视。 Objective To investigate the antibiotic resistance in the clinical isolates collected in Chuzhou hospitals during 2013.Methods Antimicrobial susceptibility testing was carried out by Kirby-Bauer method.The data were analyzed by using WHONET5.6 software according to CLSI 2012 breakpoints.Results A total of 2 927 clinical isolates were collected during2013,of which gram positive organisms and gram negative organisms accounted for 26.1% and 73.9%,respectively.The prevalence of methicillin-resistant strains among S.aureus and coagulase-negative isolates were 33.2% and 85.9%,respectively.Staphylococcus,E.faecalis and E.faeciumisolates were 100% susceptible to vancomycin and linezolid.The prevalence of extended-spectrumβ-lactamases(ESBLs)positive strains was 56.9%,31.3% and 22.8%in E.coli,Klebsiella spp.(K.pneumoniae and K.oxytoca)and P.mirabilis,respectively.The Enterobacteriaceae strains were highly sensitive to carbapenems.The percentage of the P.aeruginosa isolates resistant to meropenem,imipenem,amikacin,piperacillintazobactam or ceftazidime was lower than 30%.The percentage of Acinetobacter spp.strains resistant to meropenem and imipenem was 58.1% and 50.2%.Conclusions The issue of antibiotic resistance is still very serious in 2013,especially the emerging multi-drug or pan-drug resistant strains,which is of great concern.
出处 《中国感染与化疗杂志》 CAS CSCD 北大核心 2015年第2期167-170,共4页 Chinese Journal of Infection and Chemotherapy
关键词 耐药性 多重耐药 泛耐药 antibiotic resistance multi-drug resistance pan-drug resistance
作者简介 谢强(1982--),男,硕士,检验师,主要从事细菌耐药研究。通信作者:谢强,E-mail:xieqiang0912@163.com。
  • 相关文献

参考文献8

  • 1Clinical and Laboratory Standards Institute (CINI) . Performance standards for Antimicrobial susceptibility testing[S]. 2012, M100-$22.
  • 2沈智勇,宋有良,王谦,潘晓龙,周东升,黄丽,钱泽平,刘三保,陈自武,朱向阳.安徽省铜陵地区2011年细菌耐药性监测[J].中国感染与化疗杂志,2013,13(6):450-455. 被引量:8
  • 3汪复,朱德妹,胡付品,蒋晓飞,胡志东,李全,孙自镛,陈中举,徐英春,张小江,王传清,王爱敏,倪语星,孙景勇,褚云卓,俞云松,林洁,徐元宏,沈继录,苏丹虹,卓超,魏莲花,吴玲,张朝霞,季萍,张泓,孔菁,胡云建,艾效曼,单斌,杜艳.2012年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2013,13(5):321-330. 被引量:466
  • 4刘彩林,陈中举,孙自镛,曹伟,冯羡菊,王山梅,曾吉,邹明祥,汪明,孙明月,侯红艳.中南地区金黄色葡萄球菌流行病学及耐药性研究[J].中华微生物学和免疫学杂志,2013,33(6):410-415. 被引量:3
  • 5肖永红,沈萍,魏泽庆,陈云波,孔海深,杨青,张伟丽,陈晓,李兰娟.Mohnarin 2011年度全国细菌耐药监测[J].中华医院感染学杂志,2012,22(22):4946-4952. 被引量:366
  • 6朱德妹,汪复,郭燕,杨洋,蒋晓飞,王传清,王爱敏,刘瑛,陈峰,倪语星,孙景勇,王靖,李虎,汤瑾,王坚镪,应春妹,汪雅萍,张泓,孔菁,魏丽,王金铎,袁应华,刘妍,胡必杰,黄声雷,陈险峰,殷杏,刘庆中,汤荣,袁轶群,武楠,傅启华,黄卫春,杨海慧,卫颖珏,孙康德,虞中敏,唐群力,冯景,康向东,戴俊华,张正银,孙晴,孙杰,沈思娣,秦云,钱敏健,王蓉,沈燕雅,彭敬红,刘军,朱祖怀,陈超,唐之俭,王芳,汪瑞忠,房华,范惠清,严育忠,朱学源,龚炜.2012年上海地区细菌耐药性监测[J].中国感染与化疗杂志,2013,13(6):409-419. 被引量:51
  • 7Qi Y,Wei ZQ,Ji S, et al. ST11, the dominant clone of KPC- producing Klebsiella Dneumoniae in China[J]. J Antimicrob Chemother,2011,66(2) :31)7 312.
  • 8胡付品,朱德妹,汪复,蒋晓飞,杨青,徐英春,张小江,孙自镛,陈中举,王传清,王爱敏,倪语星,孙景勇,俞云松,林洁,单斌,杜艳,徐元宏,沈继录,张泓,孔菁,卓超,苏丹虹,张朝霞,季萍,胡云建,艾效曼,黄文祥,贾蓓,魏莲花,吴玲.2011年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2012,12(5):321-329. 被引量:527

二级参考文献76

  • 1朱德妹,张婴元,汪复,郭燕,蒋晓飞,倪语星,孙景勇,应春妹,汪雅萍,王传清,王爱敏,蒋燕群,汤瑾,张泓,李万华,沈燕雅,金文敏,周庭银,陈险峰,张蓓,黄卫春,杨海慧,卫颖珏,汤荣,丁星,吴丽桂,武楠,汪瑞忠,房华,吕新华,朱爱英.2009年上海地区细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):403-413. 被引量:37
  • 2XIONG Zi-zhong ZHU De-mei WANG Fu ZHANG Ying-yuan.CTX-M-14, CTX-M-24 and resistance in Escherichia coli and Klebsiella pneumoniae clinical isolates[J].Chinese Medical Journal,2006(2):160-164. 被引量:13
  • 3Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J]. N Engl J Med, 2009, 360(5) : 439-443.
  • 4Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Tweenty-first in- formational supplement, 2011, M100-S21 Vol 31 No. 1.
  • 5Falagas ME, Giannopoulou KP, Kokolakis GN, et al. Fosfo- mycin: use beyond urinary tract and gastrointestinal infec tions[J]. Clin Infect Dis, 2008, 46(7): 1069-1077.
  • 6Olsson-Liljequist B, Burman LG. Introducing fosfomycin for surgical prophylaxis-emergence of resistance in aerobic faecal gram-negative bacteria of in patients, but not among strains causing infection after elective colorectal procedures [J ]. Scand J Infect Dis, 1993, 25(6) :725-733.
  • 7Andaker L, Burman LG, Eklund A, et al. Fosfomycin/met- ronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective coloreetal surgery: a randomised double blind multicentre trial in 517 patients[J]. Eur J Surg, 1992, 158(3):181 185.
  • 8Nohr M, Andersen JC, Juul-Jensen KE. Prophylactic single dose fosfomycin and metronidazole compared with neomycin, haeitraein, metronidazole and ampicillin in elective colorectal operations[J]. Acta Chir Seand, 1990, 156(3):223-230.
  • 9Lindhagen J, Hadziomerovic A, Nordlung S, et al. Comparison of systemic prophylaxis with metronidazole-fosfomycin and met- ronidazole-cephalothin in elective colorectal surgery[J]. Acta Chir Scand, 1981, 147(4):277-283.
  • 10David MZ, Daum RS. Community-associated methicillin-resistant Stapylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev, 2010, 23 (3) : 616- 687.

共引文献1258

同被引文献39

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部